Qinghua Hu

10PUBLICATIONS
10CO-AUTHORS
Molecular medicineEpidemiological modellingBiologically active moleculesBiomolecular modelling and designMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Nov 03, 2025
Discovery of Novel P2Y14R Inhibitors for Ameliorating Liver Fibrosis by Suppressing Hepatic Stellate Cell Activation.

Chencheng Li, Hui Wang, Li Liu

|Oct 27, 2025
Targeting P2Y14R alleviates platelet-induced NET formation and venous thrombosis through PKA/AKAP13/RhoA axis.

Yafei Fang, Jie Wang, Chunxiao Liu

|Jul 03, 2024
Discovery of a Series of 4-Amide-thiophene-2-carboxyl Derivatives as Highly Potent P2Y14 Receptor Antagonists for Inflammatory Bowel Disease Treatment.

Yu-Hang Wang, Chun-Xiao Liu, Yi-Han Zhang

|Apr 02, 2024
Design, Synthesis, and Biological Evaluation of a Novel NIK Inhibitor with Anti-Inflammatory and Hepatoprotective Effects for Sepsis Treatment.

Nanxia Zhang, Shige Shen, Mengyu Yang

|Mar 07, 2024
Targeting P2Y14R protects against necroptosis of intestinal epithelial cells through PKA/CREB/RIPK1 axis in ulcerative colitis.

Chunxiao Liu, Hui Wang, Lu Han

|Nov 30, 2023
Macrophage P2Y6 receptor deletion attenuates atherosclerosis by limiting foam cell formation through phospholipase Cβ/store-operated calcium entry/calreticulin/scavenger receptor A pathways.

Yehong Li, Mengze Zhou, Huanqiu Li

Pageof 2

Frequent Collaborators

3 joint publications

Huanqiu Li

2 joint publications

Yadong Chen

1 joint publications

Li-Li Xu

1 joint publications

Zhen-Hua Ding